MYM Nutraceuticals Inc. vs. My Marijuana Inc.
Seite 7 von 39 Neuester Beitrag: 23.07.21 12:44 | ||||
Eröffnet am: | 01.11.16 10:15 | von: GoldenStock | Anzahl Beiträge: | 967 |
Neuester Beitrag: | 23.07.21 12:44 | von: JT_Marlin | Leser gesamt: | 400.455 |
Forum: | Hot-Stocks | Leser heute: | 107 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 4 | 5 | 6 | | 8 | 9 | 10 | ... 39 > |
During the nine months ended February 28, 2017 the Company issued the following shares:
• 746,748 units were issued at a price of $0.035 per unit for gross proceeds of $26,125. Each
unit consists of one common share and one non-transferable share purchase warrant. Each
warrant entitles the holder to acquire one additional common share exercisable until October
18, 2018 at a price of $0.05 per warrant share. No finders’ fees are payable on this
placement.
• 8,100,000 units were issued at a price of $0.05 per unit for gross proceeds of $405,000. Each
unit consists of one common share and one non-transferable share purchase warrant. Each
warrant entitles the holder to acquire one additional common share exercisable until
February 9, 2019 at a price of $0.07 per warrant share. No finders’ fees are payable on this
placement.
• 935,000 shares were issued for the exercising of warrants at $0.05 per share for gross
proceeds of $46,750.
• 1,000,000 shares were issued for the 51% acquisition of Sublime Culture Inc at a price or
$0.065 per share for a value of $65,000
Quelle siehe #150.
Innerhalb von 1 Woche sind ca. 30 Mio Aktien gehandelt worden. Selbst WENN ( wenn )
die Altaktionäre ( die haben es auch verdient ) Kasse machen - sind die 10 Mio Shares
schnell vom Markt aufgenommen.
Was ich aber glaube: Keiner - auch keiner vom Management - die ein bisschen Hintergrund
Wissen haben - wird zu Kursen unter 1 Dollar - oder vielleicht auch nicht unter 5 Dollar verkaufen.
m. Meinung !!
Korrekturen - wie die letzen 2 Tage sind nötig und wichtig - damit der Kurs gesund weiter steigen kann. Die nervösen gehen raus - die "Longs" - wie ich - bleiben ganz gelassen drinnen.
Vancouver, B.C. / TheNewswire / June 29, 2017 – MYM Nutraceuticals Inc. (CSE: MYM ) (OTC: MYMMF ) , is extremely pleased to announce that GGS Structures and CannaCanada Inc., subsidiary of MYM, are working together on the planning and design of the 1.5 Million sq. ft. Weedon Cannabis Greenhouse Production Project.
Gerry Harrison of GGS Structures commented, "We are thrilled to be working with MYM Nutraceuticals on their project located at Weedon, Quebec. Planning is underway for the first phase of a greenhouse medical cannabis cultivation facility of approximately 100,000 sf. The completed state of the art growing facility will consist of 15 greenhouses that will total 1,500,000 sq. sf."
GGS Structures is Canada's leading expert manufacturers in cannabis greenhouse & indoor cannabis grow systems. The GGS cannabis division focuses on providing smart agricultural technology geared to increasing production yield and consistent quality of medical grade cannabis. Learn more about GGS Structures at http://www.ggs-greenhouse.com.
Weedon License Submitted
Weedon Health Canada commercial cannabis production license application has been submitted. MYM's consultants Factotum Consultants, who have successfully obtained Licensed Producer licenses for other clients, are managing the ACMPR application process and have submitted the Weedon application to Health Canada on June 28, 2017.
Weedon Quality Assurance Position Filled
MYM is pleased to announce that David O’Halloran, BSc. has joined the MYM/CanaCanada team as the Quality Assurance Person for the Weedon Project. David O’Halloran brings sixteen years of Quality Assurance and Regulatory Affairs experience to the team. Having graduated from the Cork Institute of Technology in Ireland with a Bachelor of Science in Pharmaceutical Chemistry, David spent five years working in the laboratories of Novartis in the south Coast of Ireland. In 2006, he immigrated to Canada where he began working for PharmAthene Canada Inc., the Canadian division of an American biotech company contracted by the US Department of Defense to develop countermeasures for chemical and biological warfare. Following that he spent two years as Quality Assurance and Regulatory Affairs Director with Vivier Pharma.
David has since been consulting for companies to obtain their licenses from Health Canada, first under the Marihuana for Medical Purposes Regulations (MMPR), and later, the Access to Cannabis for Medical Purposes Regulations (AMPR), submitting applications on behalf of the companies, setting up quality managements systems and helping in the design of production facilities to ensure optimal production efficiency and regulatory compliance. The Quality Assurance position is one of the most critical and scrutinized parts of all licensing applications and is where most applications are lacking causing long delays or non issuance. David is a great addition to our team bringing with him many years of invaluable, specialized cannabis licensing experience and expertise.
MYM Nutraceuticals Inc. (CSE:MYM)(OTC:MYMMF)(FRA:OMY) is a public company trading on the Canadian Stock Exchange whose primary focus is developing high-end organic medicinal cannabis supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market.
ON BEHALF OF THE BOARD
“ Rob Gietl”
Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mymarijuana.ca
MYM Investor Relations Contact info:
Terry Brown
Tel: 1-855-696-2261
You can email Mr. Brown here: http://www.mymarijuana.ca/contact-us/
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
Lest euch mal die Filings durch.
Dienstag den 04.07 ist Feiertag in US.
finde die jungs toll, genau wie auch das lockere gute gespräch.
das wichtigste fand ich
Das Management hät ca. 30 Prozent der Aktien
Es sind ca. 84 Millionen Aktien draussen
uuuuund es wird eine PP kommen
Vancouver, B.C., June 1, 2017 – MYM Nutraceuticals Inc., (CSE: MYM) (the
“Company” or “MYM”) is pleased to announce it has closed its non-brokered private
placement of 5,502,120 units at a price of $0.18 per unit for gross proceeds of
$990,381.60. Each unit in the private placement is comprised of one common share and one nontransferable share purchase warrant with each warrant exercisable into one additional
common share at a price of $0.40 for a period of one year and the securities will be
subject to a four month and one day hold period under securities laws.
A finder’s fee of $720.00 was paid on the financing. The Company intends to use the net proceeds from the private placement for general working capital and corporate purposes
$0.18 (commons) sind umgerechnet akt. 0,122 Euro.
$0.40 (warrants) sind umgerechnet akt. 0,27 Euro.
Jun 1 2017 - 11:24:08 ET - News release - English
http://www.sedar.com/...anyDocuments.do?lang=EN&issuerNo=00036308
Es sei denn, ich habe etwas übersehen - das möchte ich nicht ausschließen.
Das PP kam dann kurz danach zum 01.Juni.
Wer aufpasst ist klar im Vorteil :-)
Das Interview ist daher sicherlich schon 4-5 Wochen alt gewesen, bedenkt das bitte,
auch Grüsse an @tbhomy - der sonst immer alles ganz genau weiß,
und besser weiß wie wir alle.
Sie sind ehrlich... Sie haben gerade ein PP abgeschlossen...
Aber um die ganzen Beteiligungen vorwärts zu bekommen,
Wird innerhalb der nächsten 2 Wochen ein neues announcment über eine pp rauskommen.
Der interviewer sagt am Schluss das die Verkündung in den Zeitraum der Veröffentlichung des Videos fallen wird.
Ich weiß nicht wann das alles war. Das Interview an welchem Tag.
Hatte mir auch gedacht das es das am 01.06. sein kann.
Aber wenn ihr das wiederum richtig verstehe war am 01.06. die Meldung das die PP erfolgreich abgeschlossen wurde...
Das könnte ja theoretisch die sein die die im Video meinten...mit eben abgeschlossen.
Das würde bedeuten es kommt noch die angekündigte....
Wie auch immer... Irgendwann wird wieder eine kommen
Und MYM mietet diese Gebäude von diesen zurück.
Investition / Geldbedarf hält sich in Grenzen - evtl. mit Option auf Kauf der kompletten Anlage
in 2-3-4 Jahren !!??
Was haltet ihr davon ?
Denke das ist auch hier in Deutschland eine übliche Finanzierung - z.B. auch bei
der Erstellung von Supermärkten usw.....
Der Bauträger streckt das Geld vor - und der Betreiber ( hier MYM ) mietet das langfrisitg.....